2024-01-012024-12-312024-12-31false10403421SYNVERT TCM LIMITED2025-04-0962012falseiso4217:GBPxbrli:pure104034212024-01-01104034212024-12-31104034212024-01-012024-12-31104034212023-01-01104034212023-12-31104034212023-01-012023-12-3110403421bus:SmallEntities2024-01-012024-12-3110403421bus:AuditExempt-NoAccountantsReport2024-01-012024-12-3110403421bus:AbridgedAccounts2024-01-012024-12-3110403421bus:PrivateLimitedCompanyLtd2024-01-012024-12-3110403421core:WithinOneYear2024-12-3110403421core:AfterOneYear2024-12-3110403421core:WithinOneYear2023-12-3110403421core:AfterOneYear2023-12-3110403421core:ShareCapital2024-12-3110403421core:SharePremium2024-12-3110403421core:RevaluationReserve2024-12-3110403421core:OtherReservesSubtotal2024-12-3110403421core:RetainedEarningsAccumulatedLosses2024-12-3110403421core:ShareCapital2023-12-3110403421core:SharePremium2023-12-3110403421core:RevaluationReserve2023-12-3110403421core:OtherReservesSubtotal2023-12-3110403421core:RetainedEarningsAccumulatedLosses2023-12-3110403421core:LandBuildings2024-12-3110403421core:PlantMachinery2024-12-3110403421core:Vehicles2024-12-3110403421core:FurnitureFittings2024-12-3110403421core:OfficeEquipment2024-12-3110403421core:NetGoodwill2024-12-3110403421core:IntangibleAssetsOtherThanGoodwill2024-12-3110403421core:ListedExchangeTraded2024-12-3110403421core:UnlistedNon-exchangeTraded2024-12-3110403421core:LandBuildings2023-12-3110403421core:PlantMachinery2023-12-3110403421core:Vehicles2023-12-3110403421core:FurnitureFittings2023-12-3110403421core:OfficeEquipment2023-12-3110403421core:NetGoodwill2023-12-3110403421core:IntangibleAssetsOtherThanGoodwill2023-12-3110403421core:ListedExchangeTraded2023-12-3110403421core:UnlistedNon-exchangeTraded2023-12-3110403421core:LandBuildings2024-01-012024-12-3110403421core:PlantMachinery2024-01-012024-12-3110403421core:Vehicles2024-01-012024-12-3110403421core:FurnitureFittings2024-01-012024-12-3110403421core:OfficeEquipment2024-01-012024-12-3110403421core:NetGoodwill2024-01-012024-12-3110403421core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3110403421core:ListedExchangeTraded2024-01-012024-12-3110403421core:UnlistedNon-exchangeTraded2024-01-012024-12-3110403421core:MoreThanFiveYears2024-01-012024-12-3110403421core:Non-currentFinancialInstruments2024-12-3110403421core:Non-currentFinancialInstruments2023-12-3110403421dpl:CostSales2024-01-012024-12-3110403421dpl:DistributionCosts2024-01-012024-12-3110403421core:LandBuildings2024-01-012024-12-3110403421core:PlantMachinery2024-01-012024-12-3110403421core:Vehicles2024-01-012024-12-3110403421core:FurnitureFittings2024-01-012024-12-3110403421core:OfficeEquipment2024-01-012024-12-3110403421dpl:AdministrativeExpenses2024-01-012024-12-3110403421core:NetGoodwill2024-01-012024-12-3110403421core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3110403421dpl:GroupUndertakings2024-01-012024-12-3110403421dpl:ParticipatingInterests2024-01-012024-12-3110403421dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3110403421core:ListedExchangeTraded2024-01-012024-12-3110403421dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3110403421core:UnlistedNon-exchangeTraded2024-01-012024-12-3110403421dpl:CostSales2023-01-012023-12-3110403421dpl:DistributionCosts2023-01-012023-12-3110403421core:LandBuildings2023-01-012023-12-3110403421core:PlantMachinery2023-01-012023-12-3110403421core:Vehicles2023-01-012023-12-3110403421core:FurnitureFittings2023-01-012023-12-3110403421core:OfficeEquipment2023-01-012023-12-3110403421dpl:AdministrativeExpenses2023-01-012023-12-3110403421core:NetGoodwill2023-01-012023-12-3110403421core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3110403421dpl:GroupUndertakings2023-01-012023-12-3110403421dpl:ParticipatingInterests2023-01-012023-12-3110403421dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-012023-12-3110403421core:ListedExchangeTraded2023-01-012023-12-3110403421dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-012023-12-3110403421core:UnlistedNon-exchangeTraded2023-01-012023-12-3110403421core:NetGoodwill2024-12-3110403421core:IntangibleAssetsOtherThanGoodwill2024-12-3110403421core:LandBuildings2024-12-3110403421core:PlantMachinery2024-12-3110403421core:Vehicles2024-12-3110403421core:FurnitureFittings2024-12-3110403421core:OfficeEquipment2024-12-3110403421core:AfterOneYear2024-12-3110403421core:WithinOneYear2024-12-3110403421core:ListedExchangeTraded2024-12-3110403421core:UnlistedNon-exchangeTraded2024-12-3110403421core:ShareCapital2024-12-3110403421core:SharePremium2024-12-3110403421core:RevaluationReserve2024-12-3110403421core:OtherReservesSubtotal2024-12-3110403421core:RetainedEarningsAccumulatedLosses2024-12-3110403421core:NetGoodwill2023-12-3110403421core:IntangibleAssetsOtherThanGoodwill2023-12-3110403421core:LandBuildings2023-12-3110403421core:PlantMachinery2023-12-3110403421core:Vehicles2023-12-3110403421core:FurnitureFittings2023-12-3110403421core:OfficeEquipment2023-12-3110403421core:AfterOneYear2023-12-3110403421core:WithinOneYear2023-12-3110403421core:ListedExchangeTraded2023-12-3110403421core:UnlistedNon-exchangeTraded2023-12-3110403421core:ShareCapital2023-12-3110403421core:SharePremium2023-12-3110403421core:RevaluationReserve2023-12-3110403421core:OtherReservesSubtotal2023-12-3110403421core:RetainedEarningsAccumulatedLosses2023-12-3110403421core:NetGoodwill2023-01-0110403421core:IntangibleAssetsOtherThanGoodwill2023-01-0110403421core:LandBuildings2023-01-0110403421core:PlantMachinery2023-01-0110403421core:Vehicles2023-01-0110403421core:FurnitureFittings2023-01-0110403421core:OfficeEquipment2023-01-0110403421core:AfterOneYear2023-01-0110403421core:WithinOneYear2023-01-0110403421core:ListedExchangeTraded2023-01-0110403421core:UnlistedNon-exchangeTraded2023-01-0110403421core:ShareCapital2023-01-0110403421core:SharePremium2023-01-0110403421core:RevaluationReserve2023-01-0110403421core:OtherReservesSubtotal2023-01-0110403421core:RetainedEarningsAccumulatedLosses2023-01-0110403421core:AfterOneYear2024-01-012024-12-3110403421core:WithinOneYear2024-01-012024-12-3110403421core:Non-currentFinancialInstrumentscore:CostValuation2024-01-012024-12-3110403421core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-012024-12-3110403421core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-012024-12-3110403421core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-012024-12-3110403421core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-012024-12-3110403421core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-012024-12-3110403421core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3110403421core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3110403421core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3110403421core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3110403421core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3110403421core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3110403421core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3110403421core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3110403421core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3110403421core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3110403421core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3110403421core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3110403421core:Non-currentFinancialInstrumentscore:CostValuation2023-12-3110403421core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-3110403421core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-3110403421core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-3110403421core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-3110403421core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-3110403421core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-3110403421core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-3110403421core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-3110403421bus:Director12024-01-012024-12-3110403421bus:Director22024-01-012024-12-3110403421bus:Director32024-01-012024-12-3110403421bus:Director42024-01-012024-12-31

SYNVERT TCM LIMITED

Registered Number
10403421
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2024

SYNVERT TCM LIMITED
Company Information
for the year from 1 January 2024 to 31 December 2024

Directors

COLLINS, Ronald Anthony
DEMPSEY, David
FIDDAMAN, Robert John
HUTCHINSON, Mark Edward John

Registered Address

Dalton Place
29 John Dalton Street
Manchester
M2 6DS

Registered Number

10403421 (England and Wales)
SYNVERT TCM LIMITED
Balance Sheet as at
31 December 2024

Notes

2024

2023

£

£

£

£

Current assets
Debtors3357,874388,245
Cash at bank and on hand213,64880,070
571,522468,315
Prepayments and accrued income13,8008,085
Creditors amounts falling due within one year4(320,406)(448,486)
Net current assets (liabilities)264,91627,914
Total assets less current liabilities264,91627,914
Creditors amounts falling due after one year(101,360)(889,549)
Net assets163,556(861,635)
Capital and reserves
Called up share capital1,604,696449,444
Profit and loss account(1,441,140)(1,311,079)
Shareholders' funds163,556(861,635)
The financial statements were approved and authorised for issue by the Board of Directors on 9 April 2025, and are signed on its behalf by:
HUTCHINSON, Mark Edward John
Director
Registered Company No. 10403421
SYNVERT TCM LIMITED
Notes to the Financial Statements
for the year ended 31 December 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
2.Average number of employees

20242023
Average number of employees during the year1721
3.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables157,461261,473
Other debtors60049,758
Prepayments and accrued income199,81377,014
Total357,874388,245
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
4.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables184,761146,552
Bank borrowings and overdrafts41,78148,732
Taxation and social security52,217133,766
Accrued liabilities and deferred income41,647119,436
Total320,406448,486
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.